White blood cell counts in persons aged 65 years or more from the cardiovascular health study: Correlations with baseline clinical and demographic characteristics

American Journal of Epidemiology

Volumn 143, Issue 11, 1996, Pages 1107-1115

  Bovill, Edwin G ^a   Bild, Diane E ^b   Heiss, Gerardo ^c   Kuller, Lewis H ^d   Lee, Marshall H ^e   Rock, Robert ^f   Wahl, Patricia W ^g  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c The University of North Carolina at Chapel Hill   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f American Society for Clinical Pathology   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

Author keywords

aged; blood cells; cardiovascular diseases; leukocyte count; risk factors

Indexed keywords

CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BODY HEIGHT; CORONARY RISK; CREATININE BLOOD LEVEL; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOSE METABOLISM; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SMOKING; STROKE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029888201     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008687     Document Type: Article

References (39)

1. Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974;290:1275-8.
2. Zalokar JB, Richard JL, Claude JR. Leukocyte count, smoking, and myocardial infarction. N Engl J Med 1981;304: 465-8.
3. Prentice RL, Szatrowski TP, Fujikura T, et al. Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol 1982;116:496-509.
4. Grimm RH Jr, Neaton PD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and allcause mortality. JAMA 1985;254:1932-7.
5. Yarnell JW, Baker IA, Sweetnam PM. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991;83:836-44.
6. Lowe GD, Machado SG, Krol WF, et al. White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost 1985;54:700-3.
7. Schlant RC, Forman S, Stamler J, et al. The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the Coronary Drug Project. Circulation 1982;66:401-14.
8. Prentice RL, Szatrowski TP, Kato H, et al. Leukocyte counts and cerebrovascular disease. J Chronic Dis 1982;35:703-14.
9. Nieto FJ, Szklo M, Folsom AR, et al. Leukocyte count correlates in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1992;136: 525-37.
10. Olivares R, Ducimetiere P, Claude JR. Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol 1993;137: 49-53.
11. Friedman GD, Tekawa I, Grimm RH, et al. The leucocyte count: correlates and relationship to coronary risk factors. The CARDIA Study. Int J Epidemiol 1990;19:889-93.
12. Friedman GD, Siegelaub AB, Seltzer CC, et al. Smoking habits and the leukocyte count. Arch Environ Health 1973;26: 137-43.
13. Petitti DB, Kipp H. The leukocyte count: associations with intensity of smoking and persistence of effect after quitting. Am J Epidemiol 1986;123:89-95.
14. Hansen LK, Grimm RH Jr, Neaton JD. The relationship of white blood cell count to other cardiovascular risk factors. Int J Epidemiol 1990;19:881-8.
15. Ernst E, Hammerschmidt DE, Bagge U, et al. Leukocytes and risk of ischemic diseases. JAMA 1987;257:2318-24.
16. Kannel WB, Vokonas PS. Primary risk factors for coronary heart disease in the elderly: The Framingham Study. In: Wenger NK, Furberg D, Pitt E, eds. Coronary heart disease in the elderly. New York, NY: Elsevier Science Publishing Company, Inc, 1986:60-95.
17. Rose G, Shipley M. Plasma cholesterol concentration and death from coronary heart disease: 10 year results of the Whitehall Study. Br Med J (Clin Res Ed) 1986;293:306-7.
18. Seltzer CC. Smoking and coronary heart disease in the elderly. Am J Med Sci 1975;269:309-15.
19. Langer RD, Ganiats TG, Barrett-Connor E. Paradoxical survival of elderly men with high blood pressure. BMJ 1989;298: 1356-7.
20. Mattila K, Haavisto M, Rajala S, et al. Blood pressure and five year survival in the very old. Br Med J (Clin Res Ed) 1988; 296:887-9.
21. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991;1: 263-76.
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
23. Gardin JM, Wong ND, Bommer W, et al. Echocardiographic design of a multicenter investigation of free-living elderly subjects: The Cardiovascular Health Study. J Am Soc Echocardiogr 1992;5:63-72.
24. O'Leary DH, Polak JF, Wolfson SK Jr, et al. Use of sonography to evaluate carotid atherosclerosis in the elderly: The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 1991;22:1155-63.
25. Caird FI, Andrews GR, Gallie TB. The leucocyte count in old age. Age Ageing 1972;1:239-44.
26. Cruickshank JM, Alexander MK. The effect of age, sex, parity, haemoglobin level, and oral contraceptive preparations on the normal leucocyte count. Br J Haematol 1970;18: 541-50.
27. Shapleigh JB, Mayes S, Moore CV. Hematologic values in the aged. J Gerontol 1952;7:207-13.
28. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med 1986;314:488-500.
29. Lowe GD, Wood DA, Douglas JT, et al. Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina. Thromb Haemost 1991;65:339-43.
30. Meade TW. The epidemiology of haemostatic and other variables in coronary artery disease. In: XIth International Congress on Thrombosis and Haemostasis, Brussels, Belgium, July 11, 1987. New York, NY: Pergamon Press, 1987.
31. Hunt BJ. The relation between abnormal hemostatic function and the progression of coronary disease. Curr Opin Cardiol 1990;5:758-65.
32. Elwood PC, Beswick AD, Sharp DS, et al. Whole blood impedance platelet aggregometry and ischemic heart disease: The Caerphilly Collaborative Heart Disease Study. Arteriosclerosis 1990;10:1032-6.
33. Davies PF. Vascular cell interactions with special reference to the pathogenesis of atherosclerosis. Lab Invest 1986;55:5-24.
34. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129-35.
35. Kuller LH, Eichner JE, Orchard TJ, et al. The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. Am J Epidemiol 1991;134:1266-77.
36. Mercuri M, Ciuffetti G, Robinson M, et al. Blood cell rheology in acute cerebral infarction. Stroke 1989;20:959-62.
37. Ciuffetti G, Mercuri M, Rizzo MT, et al. Human leucocyte rheology and tissue ischaemia. Eur J Clin Invest 1989;19:323-7.
38. Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 1989;9:2752-5.
39. Furie B, Furie BC. Molecular and cellular biology of blood coagulation. N Engl J Med 1992;326:800-6.